作者
L Ryom, A Cotter, R De Miguel, Charles Béguelin, D Podlekareva, JR Arribas, Catia Marzolini, PGM Mallon, Andri Rauch, Ole Kirk, JM Molina, G Guaraldi, A Winston, S Bhagani, Paola Cinque, Joanna D Kowalska, S Collins, Manuel Battegay, EACS Governing Board, Rosa De Miguel Buckley, Antonella d'Arminio Monforte, Margherita Bracchi, Nikos Dedes, Andrzej Horban, Christine Katlama, Inga Latysheva, Jens D Lundgren, Sheena McCormack, Cristina Mussini, Anton Pozniak, Federico Pulido, François Raffi, Peter Reiss, Hans‐Jürgen Stellbrink, Marta Vasylyev, Sara Gibbons, Françoise Livio, Georg Behrens, Mark Bower, Juliet Compston, Stéphane De Wit, Leonardo M Fabbri, Christoph A Fux, Magnus Gisslen, Jens D Lundgren, Esteban Martínez, José M Miro, Eugenia Negredo, Neil Poulter, Peter Reiss, Giada Sebastiani, Juan Berenguer, Christoph Boesecke, Raffaele Bruno, Svilen Konov, Karine Lacombe, Stefan Mauss, Luís Mendão, Lars Peters, Massimo Puoti, Jürgen K Rockstroh, Juan Ambrosioni, Nathalie De Castro, Gerd Fätkenheuer, Hansjakob Furrer, José M Miro, Cristiana Oprea, Anton Pozniak, Alain Volny‐Anne, Jürgen K Rockstroh, Ann Sullivan, Esteban Martínez, Fiona Mulcahy, Antonella d'Arminio Monforte, Georg Behrens, Christine Katlama, Jens D Lundgren, Cristina Mussini, Cristiana Oprea, Anton Pozniak, Peter Reiss, Annemarie Wensing
发表日期
2020/11
期刊
HIV medicine
卷号
21
期号
10
页码范围
617-624
简介
Background
The European AIDS Clinical Society (EACS) Guidelines cover key aspects of HIV management with major updates every two years.
Guideline highlights
The 2019 Guidelines were extended with a new section focusing on drug–drug interactions and other prescribing issues in people living with HIV (PLWH). The recommendations for treatment‐naïve PLWH were updated with four preferred regimens favouring unboosted integrase inhibitors. A two‐drug regimen with dolutegravir and lamivudine, and a three‐drug regimen including doravirine were also added to the recommended initial regimens. Lower thresholds for hypertension were expanded to all PLWH and for cardiovascular disease prevention, the 10‐year predicted risk threshold for consideration of antiretroviral therapy (ART) modification was lowered from 20% to 10%. Frailty and obesity were added as new topics. It was specified to use …
学术搜索中的文章
L Ryom, A Cotter, R De Miguel, C Béguelin… - HIV medicine, 2020
L Ryom, C Boesecke, M Bracchi, J Ambrosioni… - Highlights of the 2017 European AIDS Clinical Society …, 2015